QT
MRSN

Quantbot Technologies’s Mersana Therapeutics MRSN Stock Holding History

Quantbot Technologies’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-438
Closed -$25.4K – 1794
2023
Q4 		$25.4K Buy
+438
New +$17.6K ﹤0.01% 1414
2022
Q3 		– Sell
-38
Closed -$4K – 1902
2022
Q2 		$4K Sell
38
-336
-90% -$31.6K ﹤0.01% 1595
2022
Q1 		$37K Buy
+374
New +$43.7K ﹤0.01% 1256
2021
Q3 		– Sell
-648
Closed -$219K – 1754
2021
Q2 		$219K Buy
+648
New +$245K 0.02% 725
2020
Q4 		– Sell
-20
Closed -$9K – 1537
2020
Q3 		$9K Buy
+20
New +$10.1K ﹤0.01% 1130

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Quantbot Technologies's MRSN Position: Q1 2024 in Review

Quantbot Technologies sold out of Mersana Therapeutics (MRSN) in Q1 2024, closing a stake of 438 shares — an estimated $25.4K sold.

Quantbot Technologies first reported a position in MRSN in Q3 2020 and held it in 5 quarters. The position peaked at $219K in Q2 2021. 122 funds tracked by Wall St. Rank hold MRSN as of Q1 2024.

  • Quantbot Technologies reported no remaining Mersana Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 438 Mersana Therapeutics shares in Q1 2024, an estimated $25.4K.
  • Quantbot Technologies first reported a position in Mersana Therapeutics in Q3 2020 and held it in 5 quarters.
  • Quantbot Technologies's Mersana Therapeutics position peaked at $219K in Q2 2021.
  • 122 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.